(Q27336251)

25 June 2017

title

Patient preferences in advanced or recurrent ovarian cancer (English)

1 reference

25 June 2017

1 reference

1 reference

9

David Cella

1 reference

25 June 2017

11

Amy P Abernethy

1 reference

25 June 2017

1

Laura J Havrilesky

1 reference

25 June 2017

4

Andrew Berchuck

1 reference

25 June 2017

10

Kevin P Weinfurt

1 reference

25 June 2017

author name string

Angeles Alvarez Secord

2

1 reference

25 June 2017

Jessie A Ehrisman

3

1 reference

25 June 2017

Fidel A Valea

5

1 reference

25 June 2017

Paula S Lee

6

1 reference

25 June 2017

Stephanie L Gaillard

7

1 reference

25 June 2017

Greg P Samsa

8

1 reference

25 June 2017

Shelby D Reed

12

1 reference

25 June 2017

language of work or name

English

0 references

publication date

4 August 2014

1 reference

25 June 2017

1 reference

25 June 2017

volume

120

1 reference

25 June 2017

issue

23

1 reference

25 June 2017

page(s)

3651-3659

1 reference

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

25 June 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Patient preferences for surgical versus medical therapy for ulcerative colitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Discrete choice experiments in health economics: a review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Cancer patient preferences for quality and length of life

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Decision making and quality of life in the treatment of cancer: a review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Using conjoint analysis to elicit preferences for health care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4429767

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

29 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28940

Incorporation of bevacizumab in the primary treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28940

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28940

Reliability and validity of the functional assessment of cancer therapy-ovarian.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28940

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28940

A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced stage cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28940

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label tr

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25091693

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CNCR.28940

1 reference

25 June 2017

0 references

1 reference